Corrigendum to “Overview on Topical 5-ALA Photodynamic Therapy Use for Non Melanoma Skin Cancers”

Abstract EN

The review article titled “Overview on Topical 5-ALA Photodynamic Therapy Use for Non Melanoma Skin Cancers” [1] contained wording from the following articles: (i)In the section "20th Century Development of PDT", Wikipedia contributors, “Photodynamic therapy,” Wikipedia, The Free Encyclopedia, https://en.wikipedia.org/w/index.php?title=Photodynamic_therapy&oldid=580645976 (status at 7 November 7, 2013).

[2] (Not Cited) (ii)Buinauskaite, Evelina, Rimantas Zalinkevicius, Jurate Buinauskiene, and Skaidra Valiukeviciene.

“Pain during topical photodynamic therapy of actinic keratoses with 5-aminolevulinic acid and red light source: randomized controlled trial: pain during topical photodynamic therapy”, Photodermatology Photoimmunology & Photomedicine, 2013.

doi:10.1111/phpp.12044.

[3] (Not Cited) (iii)Wiegell, S., Hædersdal, M., Philipsen, P., Eriksen, P., Enk, C.

and Wulf, H.

(2008), Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study.

British Journal of Dermatology, 158: 740-746.

doi:10.1111/j.1365-2133.2008.08450.x.

[4] (Cited as reference 26) (iv)Thanos SM, Halliday GM, Damian DL, Nicotinamide reduces photodynamic therapy-induced immunosuppression in humans.

Br J Dermatol 2012; 167:631–6.

doi:10.1111/j.1365-2133.2012.11109.x.

[5] (Not Cited) (v)D'Orazio, John, Stuart Jarrett, Alexandra Amaro-Ortiz, and Timothy Scott.

“UV radiation and the skin”, International Journal of Molecular Sciences, 2013.

doi:10.3390/ijms140612222.

[6] (Not Cited)